Cargando…
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
We previously developed a respiratory tract vaccine candidate against Ebola virus (EBOV) based on human parainfluenza virus type 3 (HPIV3), a respiratory paramyxovirus, expressing the EBOV GP envelope protein (HPIV3/GP) from an added gene. Two doses of this vaccine candidate delivered by the intrana...
Autores principales: | DiNapoli, Joshua M., Yang, Lijuan, Samal, Siba K., Murphy, Brian R., Collins, Peter L., Bukreyev, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428043/ https://www.ncbi.nlm.nih.gov/pubmed/21034822 http://dx.doi.org/10.1016/j.vaccine.2010.10.024 |
Ejemplares similares
-
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009) -
Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019) -
Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
por: Shirvani, Edris, et al.
Publicado: (2020) -
Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2016) -
Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)